Laurion Capital Management’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,000
| Closed | -$42.8K | – | 171 |
|
|
2024
Q4 | $42.8K | Hold |
50,000
| – | – | ﹤0.01% | 148 |
|
|
2024
Q3 | $425K | Hold |
50,000
| – | – | 0.01% | 127 |
|
|
2024
Q2 | $234K | Sell |
50,000
-1,431,006
| -97% | -$6.68M | ﹤0.01% | 344 |
|
|
2024
Q1 | $10.1M | Buy |
1,481,006
+1,050,000
| +244% | +$7.14M | 0.09% | 89 |
|
|
2023
Q4 | $1.44M | Buy |
431,006
+85,106
| +25% | +$285K | 0.01% | 122 |
|
|
2023
Q3 | $861K | Hold |
345,900
| – | – | 0.01% | 146 |
|
|
2023
Q2 | $443K | Hold |
345,900
| – | – | ﹤0.01% | 198 |
|
|
2023
Q1 | $281K | Hold |
345,900
| – | – | ﹤0.01% | 189 |
|
|
2022
Q4 | $263K | Hold |
345,900
| – | – | ﹤0.01% | 176 |
|
|
2022
Q3 | $322K | Hold |
345,900
| – | – | ﹤0.01% | 212 |
|
|
2022
Q2 | $328K | Buy |
+345,900
| New | +$328K | 0.01% | 248 |
|
|
2020
Q2 | – | Sell |
-10,000
| Closed | -$327K | – | 635 |
|
|
2020
Q1 | $327K | Buy |
+10,000
| New | +$327K | ﹤0.01% | 364 |
|